Related Experiment Video

Updated: Dec 25, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.7K

Local Treatment of 'Oligometastases': Wishful Thinking is Not Supported by Available Evidence - Authors' Reply

P H Patel1, A-M Shiarli1, A C Tree1

  • 1Radiotherapy Department, The Royal Marsden Hospital, Sutton, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|March 24, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.8K

Related Experiment Videos

Last Updated: Dec 25, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.7K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K

Articles linked to this work by shared authors, journal, and citation graph.

How to focal boost in prostate cancer radiotherapy: ESTRO clinical practice consensus recommendations.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

The impact of body mass index on Esophagectomy: perioperative and oncological outcomes.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026

Is rectal preparation necessary in contemporary image-guided prostate radiotherapy?

Clinical and translational radiation oncology·2026

Does Overall Treatment Time Impact Toxicity and Clinical Outcomes After Magnetic Resonance Imaging-Guided Stereotactic Body Radiotherapy to the Prostate? An evaluation of the Multi-OutcoMe EvaluatioN of radiation Therapy Using the MR-Linac Repository.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.

ESMO open·2026

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.

ESMO open·2026

Analysis of Lymphopenia in Patients with Stage III Non-small Cell Lung Cancer Treated with Chemoradiotherapy and Consolidation Immunotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

A Systematic Review and Meta-Analysis of the Prognostic Value of Tumor Response Measurements During Radiotherapy for Head and Neck cancers.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Definitive Stereotactic Body Radiotherapy for Unresectable Primary Bone and Soft Tissue Tumors: A Single-institution Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Radiotherapy Treatment and Beyond - Mapping Radiotherapy Late Effects Service Provision in England.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Assessing the Benefit of Adjuvant Chemotherapy in Rectal Cancer: An International Real-World Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Endoscopic Salvage Following Radiotherapy for Oesophageal Cancer: A Systematic Review.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Case Report: Hidden danger in breast eczematous lesions: cutaneous metastasis from silent lung adenocarcinoma misdiagnosed as Paget's disease.

Frontiers in oncology·2026

Primary adenoid cystic carcinoma of the breast: a clinicopathological case series.

Korean journal of clinical oncology·2026

Unnatural definitions for natural experiments: a call for clarity when estimating causal effects of interventions.

Journal of epidemiology and community health·2026

Primary Merkel cell carcinoma of the submandibular region without cutaneous lesion: a case report.

Archives of craniofacial surgery·2026

When progression-free survival fails to inform: the need for event-level reporting in oligometastatic radiotherapy trials.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Orbital spindle cell neoplasm with neural differentiation: diagnostic challenges in the absence of molecular confirmation.

Archivos de la Sociedad Espanola de Oftalmologia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us